Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.13B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$1.18B |
| 3 |
Apple
AAPL
|
+$836M |
| 4 |
Alibaba
BABA
|
+$807M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$566M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$429M |
| 2 |
Boeing
BA
|
+$402M |
| 3 |
Coty
COTY
|
+$284M |
| 4 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$104M |
| 5 |
Qualcomm
QCOM
|
+$102M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 89.12% |
| 2 | Technology | 2.44% |
| 3 | Consumer Discretionary | 1.83% |
| 4 | Communication Services | 1.72% |
| 5 | Financials | 1.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3626
CALL
Navient
NAVI
$887M
| $2.65M | ﹤0.01% |
194,400
+27,200
| +16% | +$355K |
|
3627
Vertex Pharmaceuticals
VRTX
$137B
| $2.65M | ﹤0.01% |
14,470
+11,863
| +455% | +$2.07M |
|
3628
Heron Therapeutics
HRTX
$62M
| $2.65M | ﹤0.01% |
142,584
-55,244
| -28% | -$1.1M |
|
|
BERY
3629
PUT
DELISTED
Berry Global Group, Inc.
BERY
| $2.65M | ﹤0.01% |
54,886
-49,005
| -47% | -$2.36M |
|
|
GES
3630
PUT
DELISTED
Guess Inc
GES
| $2.65M | ﹤0.01% |
164,100
-2,000
| -1% | -$34.6K |
|
3631
CALL
Vanguard Morningstar Small-Cap ETF
VB
$81.3B
| $2.65M | ﹤0.01% |
16,900
-49,300
| -74% | -$7.62M |
|
3632
CALL
Fabrinet
FN
$14.8B
| $2.65M | ﹤0.01% |
53,300
+15,500
| +41% | +$819K |
|
3633
Invesco International Corporate Bond ETF
PICB
$355M
| $2.65M | ﹤0.01% |
99,387
+1,073
| +1% | +$28K |
|
3634
CALL
Amplify Alternative Harvest ETF
MJ
$117M
| $2.65M | ﹤0.01% |
6,958
+3,300
| +90% | +$1.33M |
|
3635
PUT
Turning Point Brands
TPB
$1.68B
| $2.65M | ﹤0.01% |
54,000
+38,900
| +258% | +$1.88M |
|
|
RUTH
3636
CALL
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $2.64M | ﹤0.01% |
116,300
+100
| +0.1% | +$2.44K |
|
|
GLOP
3637
PUT
DELISTED
GASLOG PARTNERS LP
GLOP
| $2.64M | ﹤0.01% |
124,300
-29,500
| -19% | -$626K |
|
3638
Tower Semiconductor
TSEM
$23.5B
| $2.64M | ﹤0.01% |
167,171
+95,998
| +135% | +$1.6M |
|
|
DAY
3639
PUT
DELISTED
Dayforce
DAY
| $2.64M | ﹤0.01% |
52,500
+18,500
| +54% | +$936K |
|
|
OILU
3640
PUT
DELISTED
ProShares UltraPro 3x Crude Oil ETF
OILU
| $2.64M | ﹤0.01% |
+119,800
| New | +$3.17M |
|
3641
Sinclair Inc
SBGI
$1.04B
| $2.63M | ﹤0.01% |
+49,116
| New | +$2.49M |
|
3642
argenx
ARGX
$64B
| $2.63M | ﹤0.01% |
18,564
+13,385
| +258% | +$1.7M |
|
3643
PUT
Viking Therapeutics
VKTX
$3.75B
| $2.62M | ﹤0.01% |
315,900
-213,500
| -40% | -$1.82M |
|
3644
Advance Auto Parts
AAP
$2.59B
| $2.62M | ﹤0.01% |
+16,996
| New | +$2.76M |
|
3645
CALL
Amphenol
APH
$194B
| $2.62M | ﹤0.01% |
109,200
-137,200
| -56% | -$3.3M |
|
3646
CALL
Moderna
MRNA
$55.1B
| $2.62M | ﹤0.01% |
178,800
-18,200
| -9% | -$391K |
|
3647
Bilibili
BILI
$6.95B
| $2.62M | ﹤0.01% |
160,775
+141,247
| +723% | +$2.28M |
|
|
PTR
3648
PUT
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $2.62M | ﹤0.01% |
47,500
-500
| -1% | -$29.9K |
|
|
VNE
3649
CALL
DELISTED
Veoneer, Inc.
VNE
| $2.62M | ﹤0.01% |
151,100
+133,400
| +754% | +$2.8M |
|
3650
Warrior Met Coal
HCC
$5.65B
| $2.62M | ﹤0.01% |
100,101
+64,763
| +183% | +$1.84M |
|
Similar funds
Jeff Yass's Q2 2019 Portfolio in Review
As of Q2 2019, Jeff Yass held 11,369 positions worth $275B, up 13% from $243B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jeff Yass deployed $17.9B of net new capital in Q2 2019, opening 2,651 new positions and adding to 3,766 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 14,345,542 shares worth $4.2B.
By sector, the portfolio is most concentrated in Miscellaneous at 89% of assets, down from 92% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Walt Disney, an estimated $429M trimmed.
- Jeff Yass's largest Q2 2019 buy was State Street SPDR S&P 500 ETF Trust: 14,345,542 shares worth $4.2B.
- Jeff Yass added most to Alphabet (Google) Class A in Q2 2019, an estimated $1.18B increase.
- Jeff Yass's biggest Q2 2019 reduction was Walt Disney, cutting an estimated $429M.
- Jeff Yass fully exited Goldcorp Inc in Q2 2019, selling an estimated $26.4M.
- Jeff Yass's ten largest holdings make up 24% of its $275B portfolio in Q2 2019.
- Jeff Yass opened 2,651 new positions and closed 1,221 in Q2 2019.
- Jeff Yass's portfolio value rose 13% quarter-over-quarter to $275B.
Based on Susquehanna International Group's 13F filing for Q2 2019, filed 14 Aug 2019.